Mounjaro is the diabetes-approved sibling of Zepbound. Same active ingredient (tirzepatide), same manufacturer (Eli Lilly), same dose strengths, but a different FDA-approved indication and a different insurance coverage landscape. If you have type 2 diabetes, Mounjaro is one of the most effective medications available. If you do not have diabetes but want tirzepatide for weight loss, Zepbound is usually the right choice.

Here is the complete breakdown of what Mounjaro actually costs in 2026, including the savings programs, insurance pathways, and telehealth alternatives.

Mounjaro Pricing at a Glance (2026)

Path to Mounjaro Monthly Cost
Retail pharmacy, no insurance ~$1,070
LillyDirect Self Pay (vials) $349-$499
Compounded tirzepatide (telehealth) $149-$499
Commercial insurance + Savings Card (diabetes) $25-$650
Medicare Part D (with diabetes) Plan-dependent

The Cash-Pay Reality: $1,070/Month at Retail

The retail cash price for Mounjaro is approximately $1,070 per month for a 28-day supply (4 pre-filled pens). Pricing is consistent across dose strengths from 2.5 mg to 15 mg, similar to its sibling Zepbound.

Path 1: Commercial Insurance + Mounjaro Savings Card (For Diabetes)

If you have type 2 diabetes and commercial insurance, this is the cheapest path. Eligible patients can pay as little as $25 per month with the Mounjaro Savings Card applied to a covered prescription.

The savings card requires:

  • Type 2 diabetes diagnosis
  • Commercial insurance (not Medicare, Medicaid, Tricare, or VA)
  • Valid prescription for type 2 diabetes (not weight loss)

Without insurance coverage but with the savings card, you can save up to $470 per fill, bringing the cost from $1,070 to roughly $600 per month.

Path 2: LillyDirect Self Pay Vials

Eli Lilly's LillyDirect Self Pay program offers tirzepatide vials at lower prices than the pre-filled pens. The program serves both Mounjaro (diabetes) and Zepbound (weight loss) patients.

Pricing as of 2026:

  • 2.5 mg dose: $349/month
  • 5 mg dose: $499/month
  • 7.5 mg dose: $499/month
  • 10 mg dose: $499/month

This is the cheapest brand-name tirzepatide option for cash-pay patients.

Path 3: Compounded Tirzepatide Through Telehealth

Compounded tirzepatide is the cheapest path overall, though it requires a telehealth consultation rather than a Mounjaro prescription specifically. Most telehealth providers prescribe compounded tirzepatide regardless of whether the patient has diabetes or is seeking weight loss.

Telehealth providers offering compounded tirzepatide in 2026:

Provider Compounded Tirzepatide Cost Notes
Eden $149-$249/mo Lowest entry pricing
GobyMeds $99-$349/mo Async-only
Henry Meds $149-$349/mo Async, refill-focused
Embody $149-$299/mo Oral compounded forms
Hims $199-$349/mo Established brand, async
Mochi Health $149-$499/mo Insurance navigation

For more on compounded versus brand-name pricing, see our brand-name vs compounded cost comparison.

Mounjaro vs Zepbound: Which Should You Choose?

Choose Mounjaro if:

  • You have type 2 diabetes — Mounjaro is FDA-approved for diabetes management and your insurance is more likely to cover it
  • Your doctor specifically prescribes it for diabetes management
  • You want the savings card discount, which requires a diabetes prescription

Choose Zepbound if:

  • You are seeking weight loss without a diabetes diagnosis — Zepbound is FDA-approved for chronic weight management
  • Your insurance covers Zepbound for weight loss (more plans now cover it)
  • You want LillyDirect Self Pay vials for weight loss specifically

The active ingredient and clinical effects are identical. The decision is about which insurance pathway and savings program you can access.

Insurance Coverage in 2026

For Diabetes:

  • Most commercial insurance plans cover Mounjaro for type 2 diabetes after prior authorization
  • Medicare Part D covers Mounjaro for diabetes (formulary placement varies by plan)
  • Medicaid coverage varies by state, but most cover for diabetes

For Weight Loss:

  • Insurance generally does NOT cover Mounjaro for off-label weight loss
  • Patients seeking insurance-covered tirzepatide for weight loss should pursue Zepbound instead
  • Starting July 2026, Medicare Part D will cover GLP-1s including Zepbound for chronic weight management

Find Affordable Tirzepatide Providers

Looking for an affordable provider? Take our 60-second provider quiz to match with the cheapest telehealth provider for your needs, or browse our complete telehealth provider comparison to see tirzepatide pricing across 14 vetted platforms.

For in-person care, browse our directory of 9,700+ verified GLP-1 clinics across all 50 states.

For more on tirzepatide pricing, see our complete cost guide, Zepbound cost breakdown, and Zepbound vs Wegovy comparison.


This article is for informational purposes only and does not constitute medical advice. Pricing reflects publicly available information as of April 2026 and may change. Mounjaro is FDA-approved for type 2 diabetes; using it off-label for weight loss should only be done under medical supervision.

Sources

  1. Eli Lilly Mounjaro prescribing information and savings program terms, 2026.
  2. LillyDirect Self Pay pricing, retrieved April 2026.
  3. CMS Medicare Part D formulary data, 2026.
  4. GLP1 Clinics telehealth provider pricing database, April 2026.